Skip to content

Mri characterIzation of Troponin Elevation After Cardiac Surgery

Characterization of Postoperative Myocardial Lesions by Cardiac MRI and Anatomo-biological Correlations With Serum Troponin in Cardiac Surgery.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04490785
Acronym
MITEC
Enrollment
38
Registered
2020-07-29
Start date
2020-12-02
Completion date
2023-01-12
Last updated
2025-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Surgery, Cardiopulmonary Bypass

Keywords

Cardiac surgery, Cardiopulmonary bypass, ischemia reperfusion, Cardiac magnetic resonance imaging

Brief summary

Cardiac surgery under cardiopulmonary bypass (CPB) induces myocardial ischemia-reperfusion injury. This myocardial attack is a well-identified independent prognostic factor of postoperative morbidity and mortality. The quantification of these myocardial lesions by the postoperative plasma release of troponin has proven its diagnostic and prognostic value. Cardiac magnetic resonance imaging (MRI) can accurately measure and characterize the size of myocardial lesions. These lesions are associated with a poor prognosis. MRI can also characterize myocardial edema secondary to ischemia-reperfusion which has not yet been studied in the context of CPB. It is therefore necessary, in a mechanistic approach, to quantify the respective share of necrosis, edema and reperfusion lesions during cardiac surgery under CPB in order to better understand these phenomena and to propose effective strategies for the prevention of these myocardial lesions.the relationship between the postoperative release of troponin and the amount of myocardial necrosis and edema measured by cardiac MRI will be assessed.The hypothesis is to demonstrate a positive correlation between imaging and biology in order to better understand the perioperative myocardial lesion processes. This is an interventional study prospective, exploratory, in cardiac imaging, non-comparative and single-center, including 30 patients.

Interventions

PROCEDUREMRI

1 MRI 5 days after surgery (-1; +4 days), with intravenous administration of gadolinium

BIOLOGICALPostoperative dosage of released troponin

Dosage of troponin I Hs H4, H8, H12, H24, H48, and H72 after the aortic cross-unclamping.

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years old * Aortic valve surgery with CEC: aortic valve replacement, Bentall, Tirone-David, Wheat with foreseeable clamping time of at least 40 minutes. * Informed consent signed

Exclusion criteria

* Emergency surgery * Other unconventional heart surgery * Aorto-coronary bypass associated with surgery * History of myocardial infarction or severe coronary artery disease, non-valvular hypertrophic cardiomyopathy (MHC) (primary MHC type, Amyloidosis) and myocarditis * Preoperative alteration of systolic function of the left ventricle (LVEF \<40%) * Presence of a contraindication to cardiac MRI (claustrophobia, pacemaker or cardiac defibrillator, metallic body, hypersensitivity to gadolinium) * Patients with a glomerular filtration rate (GFR) \<30 ml / min * Patients with permanent atrial fibrillation (ACFA) cardiac arrhythmia * Patients treated with anthracyclines * Pregnant and / or lactating woman * Patient under legal protection * Patient not benefiting from a social security system * Patient participating in another clinical study that may interfere with the results of this study.

Design outcomes

Primary

MeasureTime frameDescription
correlation between cardiac MRI and the AUC of postoperative plasma released hsTnI.5 daysCorrelation between the AUC of plasma hsTnI levels measured during the first 72 hours postoperatively (sequential basal assays then 4, 8, 12, 24, 48 and 72 hours after aortic unclamping) and the mass in grams of myocardial necrosis measured by the late enhancement in cardiac MRI on D5 postoperative. Correlations between MRI anatomical data and biological or ultrasound data will be assessed with the Pearson or Spearman correlation coefficient according to the distribution of variables and linear regression.

Secondary

MeasureTime frameDescription
AUC / serum peak hsTnI relationship and relative size of the necrosis on MRI5 daysCorrelation between the AUC of plasma hsTnI levels measured during the first 72 hours postoperatively (sequential basal assays then 4, 8, 12, 24, 48 and 72 hours after aortic unclamping) and percentage of left ventricular mass. Correlation between highest serum value recorded for each patient within 72 hours and percentage of left ventricular mass.
Relationship of hsTnI levels at 24 hours after aortic unclamping and the mass in grams of necrosis on MRI.5 daysCorrelation between the AUC of plasma hsTnI levels measured at 24 hours after aortic unclamping and the mass in grams of myocardial necrosis measured by the late enhancement in cardiac MRI on D5 postoperative.
AUC / peak serum hsTnI relationship and intensity of edema5 daysCorrelation between the AUC of plasma hsTnI levels measured during the first 72 hours postoperatively (sequential basal assays then 4, 8, 12, 24, 48 and 72 hours after aortic unclamping) and intensity of edema at MRI. Correlation between highest serum value recorded for each patient within 72 hours and intensity of edema at MRI
AUC / hsTnI serum peak relationship and the presence of microvascular obstruction lesions on MRI on postoperative D55 daysCorrelation between the AUC of plasma hsTnI levels measured during the first 72 hours postoperatively (sequential basal assays then 4, 8, 12, 24, 48 and 72 hours after aortic unclamping) and the presence of microvascular obstruction lesions on MRI on postoperative D5. Correlation between highest serum value recorded for each patient within 72 hours and the presence of microvascular obstruction lesions on MRI on postoperative D5.
Relationship between peak serum hsTnI and mass in grams of necrosis on MRI.5 daysCorrelation between highest serum value recorded for each patient within 72 hours and the mass in grams of myocardial necrosis measured by the late enhancement in cardiac MRI on D5 postoperative.
Correlations between clamping time and CEC and the size of the reperfusion lesions visible on MRI on D5 postoperative5 daysCorrelation between clamping time and the size of the reperfusion lesions visible on MRI on D5 postoperative. Correlation between CEC time and the size of the reperfusion lesions visible on MRI on D5 postoperative.
Exploratory evaluation of the kinetic profile of AUC with the type of lesion found on cardiac MRI (early peak, versus late peak).5 daysCorrelation between the kinetic profile of AUC and the type of lesion found on MRI on D5 postoperative.
Relation of functional and anatomical parameters of the right ventricle in 4 cavities and small axis (tele-diastolic volume, FEVD) evaluated by cardiac MRI on D5 postoperative.5 daysCorrelation between the right ventricle in 4 cavities and small axis (2 differents measures) on MRI on D5 postoperative.
Relation of functional and anatomical parameters evaluated by cardiac MRI on postoperative D5.5 daysTele-diastolic volume / ventricular mass, LVEF on MRI on postoperative D5.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026